WallStreetZenWallStreetZen

NASDAQ: VBIV
Vbi Vaccines Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VBIV

Based on 1 analyst offering 12 month price targets for Vbi Vaccines Inc.
Min Forecast
$6.00+806.34%
Avg Forecast
$6.00+806.34%
Max Forecast
$6.00+806.34%

Should I buy or sell VBIV stock?

Based on 1 analyst offering ratings for Vbi Vaccines Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VBIV stock forecasts and price targets.

VBIV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Bottom 8%
8
BuyMaintains$6.00+806.34%2023-04-13

1 of 1

Forecast return on equity

Is VBIV forecast to generate an efficient return?
Company
N/A
Industry
0.91%
Market
28.82%

Forecast return on assets

Is VBIV forecast to generate an efficient return on assets?
Company
N/A
Industry
0.07%

VBIV revenue growth forecast

How is VBIV forecast to perform vs Biotechnology companies and vs the US market?
Company
409.72%
Industry
35.95%
Market
8.15%
VBIV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VBIV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VBIV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VBIV$0.66$6.00+806.34%Buy
CALC$2.64$15.50+487.12%Strong Buy
PHXM$4.94N/AN/A
NNVC$1.28$5.25+310.16%Strong Buy
APRE$4.15$20.00+381.93%Buy
View Top Biotech Stocks

Vbi Vaccines Stock Forecast FAQ

Is Vbi Vaccines Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VBIV) stock is to Buy VBIV stock.

Out of 1 analyst, 0 (0%) are recommending VBIV as a Strong Buy, 1 (100%) are recommending VBIV as a Buy, 0 (0%) are recommending VBIV as a Hold, 0 (0%) are recommending VBIV as a Sell, and 0 (0%) are recommending VBIV as a Strong Sell.

If you're new to stock investing, here's how to buy Vbi Vaccines stock.

What is VBIV's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: VBIV) forecast ROE is N/A, which is considered weak.

What is VBIV's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VBIV price target, the average VBIV price target is $6.00, with the highest VBIV stock price forecast at $6.00 and the lowest VBIV stock price forecast at $6.00.

The Wall Street analyst predicted that Vbi Vaccines's share price could reach $6.00 by Apr 13, 2024. The average Vbi Vaccines stock price prediction forecasts a potential upside of 806.34% from the current VBIV share price of $0.66.

What is VBIV's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: VBIV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.